Phagenesis
Entity

  • Phagenesis

    Created in 2007


  • Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    10,412 9,971

  • Activities

    healthtech

  • Entity types

    Startup

  • Location

    Enterprise House, Lloyd St N, Manchester M15 6SE, UK

    Manchester

    United Kingdom

  • Employees

    Scale: 51-200

    Estimated: 80

  • Engaged catalyst

    0
    0 0

  • Added in Motherbase

    2 years, 5 months ago
Description
  • Value proposition

    Retrain The Brain. Restore Swallowing Control.

    Phagenyx® is the first and only clinically validated neuromodulation system that utilizes pharyngeal electrical stimulation (PES) to improve swallowing safety and efficiency to accelerate recovery from post-stroke dysphagia. Supported by 30+ publications and designed for real-world care, Phagenyx enables early intervention, resulting in a 6-day faster return to oral nutrition, >2x improvement in swallowing safety, and 8 fewer days in the hospital.

    Dysphagia treatment, Stroke rehabilitation, neurocritical care, neurostimulation, dysphagia, SpeechLanguagePathology, neuroscience, neurology, stroke, and speechlanguagetherapy

  • Phagenyx® by Phagenesis

    Retrain the brain. Restore swallowing control. Phagenyx® accelerates swallowing recovery from post-stroke dysphagia.

    • https://www.phagenesis.com/
Catalyst interactions
Catalyst Type Tweets Articles
No interactions
Social network dynamics
Last news
Show all articles